HEM Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Apr '26 Apr 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	429,136	327,494	114,874
Market Cap Growth	163.98%	185.09%	-
Enterprise Value	434,835	334,986	-
Last Close Price	59800.00	45850.00	16500.00
PS Ratio	33.06	25.23	7.62
PB Ratio	82.29	62.80	4.40
P/TBV Ratio	121.61	92.81	4.54
EV/Sales Ratio	33.50	25.81	-
Debt / Equity Ratio	3.69	3.69	0.30
Net Debt / Equity Ratio	1.05	1.05	-0.13
Net Debt / EBITDA Ratio	-0.42	-0.42	0.66
Net Debt / FCF Ratio	-0.30	-0.30	0.28
Asset Turnover	0.29	0.29	-
Inventory Turnover	9.97	9.97	-
Quick Ratio	0.38	0.38	1.73
Current Ratio	0.56	0.56	1.91
Return on Equity (ROE)	-151.43%	-151.43%	-
Return on Assets (ROA)	-21.96%	-21.96%	-
Return on Capital Employed (ROCE)	-137.30%	-137.30%	-27.60%
Earnings Yield	-5.56%	-7.28%	-6.66%
FCF Yield	-4.22%	-5.53%	-10.77%
Buyback Yield / Dilution	-10.69%	-10.69%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.